Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia

    Salvador Arias-Santiago, Miguel Angel Arrabal-Polo, Agustín Buendía-Eisman, Miguel Arrabal-Martin, María Teresa Gutiérrez-Salmerón, María Sierra Girón-Prieto, Antonio Jiménez-Pacheco, Jaime Eduardo Calonje, Ramón Naranjo-Sintes, Armando Zuluaga-Gomez, Salvio Serrano Ortega
    Image of study
    TLDR Early hair loss may indicate prostate issues.
    This study found that early-onset androgenetic alopecia (AGA) may be an early marker of urinary/prostatic symptomatology. Patients with AGA had a larger prostate, lower urinary flow value, and higher International Prostate Symptom Score (IPSS) in comparison with individuals without AGA. AGA was found to be an independent risk factor for a prostate volume greater than 30 mL, urinary flow less than 15 mL/s, and benign prostatic hyperplasia (BPH). The study suggests that dermatologists and primary care physicians should monitor patients with early-onset AGA for the development of urinary symptoms to permit an earlier diagnosis.
    Discuss this study in the Community →

    Research cited in this study

    19 / 19 results

    Related Community Posts Join

    6 / 1000+ results

      community Massive study on finasteride side effects released

      in Finasteride/Dutasteride  83 upvotes 1 year ago
      The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 1 year ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

      community Why does finasteride stop working?

      in Finasteride/Dutasteride  26 upvotes 1 month ago
      Finasteride may seem less effective over time due to increased DHT sensitivity or aging, but it still suppresses DHT. Switching to dutasteride offers stronger DHT suppression but may increase estrogen levels.

    Similar Research

    5 / 1000+ results